AlphaMaven AlphaMaven

Mayne Pharma rockets 79pc on takeover bid; Chalmers aims to cut red tape on tax; Gilbert Tobin private equity partner resigns

Reported by AFR
Nov 17, 2026· 1 min read
Save Post LinkedIn Email
Key Takeaways
  • • Mayne Pharma shares surged 79 per cent following a takeover bid from Hungarian pharmaceutical group Gedeon Richter, according to the Australian Financial Review.
  • • Treasurer Jim Chalmers is pushing to reduce compliance burdens associated with the fringe benefits tax regime.
  • • Gilbert + Tobin private equity partner David Josselsohn has resigned from the firm.
Summary
Mayne Pharma's share price rocketed 79 per cent after the company received a takeover bid from Gedeon Richter, according to the Australian Financial Review. The surge reflects the market's immediate repricing of the company on the offer, though the source article does not specify the offer price, the total transaction value, or the terms of the proposal.

Separately, Treasurer Jim Chalmers is seeking to cut red tape on fringe benefits tax, as reported by the Financial Review. The article's brief coverage does not detail the specific reforms under consideration or their expected timing.

In a personnel move, David Josselsohn, a private equity partner at law firm Gilbert + Tobin, has resigned. The Financial Review's report does not indicate the reasons for his departure or the destination of his next role.

Readers seeking further detail on the Mayne Pharma offer, the fringe benefits tax proposals, and the Gilbert + Tobin departure should refer to the full original reporting.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

AFR Mayne Pharma rockets 79pc on takeover bid; Chalmers aims to cut red tape on tax; Gilbert Tobin private equity partner resigns